Money Runners

[Robertscott]

$KRTL ~ KRTL Biotech Inc., a wholly owned subsidiary of KRTL Holding Group, Inc. (OTC: KRTL), is a research and development company that has a focus in the biotechnology space.

[Robertscott]

$HMBL HUMBL Social is the newest alternative for social media that allows verified users to connect to other verified accounts. All users must go through a 3rd party verification process in order to be approved to interact on the platform. Find, follow, and connect with other verified accounts.

[Robertscott]

$HMBL Humbl search engine has bothe web 2 and web 3 blockchain capabiities.

[Robertscott]

$HMBL Wallet is 4.9 stars and has more features than Meta Mask.

[Robertscott]

$HMBL San Diego, California, May 15, 2023 (GLOBE NEWSWIRE) -- HUMBL, Inc. (OTCQB: HMBL) announced today that it has entered into an Equity Financing Agreement with Pacific Lion LLC (Pacific Lion) pursuant to which Pacific Lion agreed to purchase up to $20,000,000 of HUMBL common stock. Pacific Lion also agreed to fund HUMBL up to $800,000 under a Convertible Promissory Note to bridge HUMBL through to the effectiveness of the registration of the shares to be sold under the Equity Financing Agreement. In addition to the transactions with Pacific Lion, HUMBL also raised $220,000 through the sale of common stock and warrants to a group of private investors.

https://seekingalpha.com/pr/19333513-humbl-receives-funding-commitment-of-up-to-21-million-initial-step-in-comprehensive-plan-to

[Robertscott]

$HMBL Wallet is 4.9 stars and has more features than Meta Mask.

[Robertscott]

$MGRX News being liked here
Mangoceuticals Inc
1.1896
+0.0196 (+1.68%)

[AyaStocks]

$EPAZ featured in another CapitalGainsReport article! >>

CapitalGainsReport: The Future of Reality: Four AR Stocks You Don't Want to Miss (EPAZ, NEXCF, SNAP, HIMX)

Augmented reality (AR) is a truly remarkable and cutting-edge technology that has the power to revolutionize the way we perceive and interact with the world around us. Unlike virtual reality, which creates a whole new world for users to explore, AR enhances the existing environment by seamlessly integrating virtual elements into it. This means that users can experience a heightened, more interactive version of reality like never before.

AR is already transforming businesses and changing the way consumers engage with them, but its potential applications are limitless. In this article, we'll delve into four exciting companies at the forefront of the AR revolution and explore how they're harnessing this incredible technology to create innovative solutions that are transforming various industries. If you're looking for the next big thing in technology, then AR could be the space to watch!

The first stock on the augmented reality watchlist is a newcomer to the space. Epazz, Inc. (OTC:EPAZ) is a mission-critical provider of metaverse solutions, drone technology, blockchain cryptocurrency mobile apps, and cloud-based business software solutions.

Last week, Epazz announced the development of a groundbreaking new product: low-cost augmented reality smart glasses called Stacklens. These durable and comfortable smart glasses are set to revolutionize the service industry, particularly field service companies, by providing access to affordable smart augmented reality glasses. Stacklens will cost less than $400 per pair, which is significantly cheaper than the $2,000 price tag of other similar products on the market.

The company decided to develop Stacklens because they noticed that third-party glasses were too expensive and caused sticker shock for potential customers in Europe who wanted to use the technology. Now, with Stacklens, organizations can use innovative technology at a low cost, enabling the company to win more deals. Stacklens is ideal for technicians in the field who need to fix complex machines such as HVAC, industrial machines, water, and waste pipes. The technology is also attracting interest in aircraft maintenance.

Epazz has submitted a proposal to the armed forces to use the technology in the field and has received feedback from the United States military about using First Person View smart glasses with ZenaDrone 1000. The company plans to continue improving the technology for use with ZenaDrone 1000, a first-person view smart glasses product with augmented reality technology.

Combining their drone technology with the low-cost augmented reality smart glasses, Stacklens, can potentially result in increased revenue for Epazz, particularly from government contracts. The United States military has already expressed interest in using their First Person View smart glasses with ZenaDrone 1000, and Epazz plans to further develop this technology. Their focus on meeting the needs of their customers by developing affordable and durable products like Stacklens highlights their commitment to innovation and customer satisfaction. As a newcomer to the augmented reality space, Epazz's potential for growth is exciting to watch.

https://www.marketscreener.com/quote/stock/EPAZZ-INC-111313555/news/CapitalGainsReport-The-Future-of-Reality-Four-AR-Stocks-You-Don-t-Want-to-Miss-EPAZ-NEXCF-SNAP-43777068/

[Robertscott]

$CBGL Traders Cheat Sheet https://cannabisglobalinc.com/new-brand-botan/

[Robertscott]

$CBGL Quote https://www.otcmarkets.com/stock/CBGL/quote

[ProfitScout]

$CURR Seratopical Products featured here today: Nicole Kidman’s Flawless Met Gala Skin Called on This Facelift in a Bottle That’s Selling Fast
By Eva Thomas  Published on May 2, 2023
LINK:
https://www.instyle.com/nicole-kidman-met-gala-2023-seratopical-revolution-7487698?utm_source=twitter&utm_medium=social&utm_campaign=shareurlbuttons

[Robertscott]

$EMED Electrotherapy is a nerve stimulation therapy via carefully developed electrical impulses mimicking our
body signals to help restore damages caused by injuries or accidents.
Significant percentage of patients found TENS devices effectively reduced their pain.

https://electromedtech.com/electrotherapy-explained/

[Robertscott]

$EMED Electrotherapy is a nerve stimulation therapy via carefully developed electrical impulses mimicking our
body signals to help restore damages caused by injuries or accidents.
Significant percentage of patients found TENS devices effectively reduced their pain.

https://electromedtech.com/electrotherapy-explained/

[Robertscott]

$EMED Electricity enables information to circulate in the body, electrotherapy manipulates a specific part of the information by pulsating electrical waves interfering with the transmission of pain signals.
Our nervous system is composed of our brain and our spinal cord, which combine to form the central nervous system; and our sensory and motor nerves, which form the peripheral nervous system. Nerves send information about what is happening in our environment to the brain via the spinal cord. The brain then sends information back to our nerves, helping us to perform actions in response. By treating specific body areas and varying frequency, wavelength and intensity applied, electrotherapy devices can manipulate impulses and target actions to alleviate pain or they can disrupt pain signals.

[Robertscott]

$EMED Electrotherapy seems to be one of the most promising substitute to toxic and addictive painkillers. Since introducing the WellnessPro+ in 2007, ElectroMedical Technologies has been an innovation pioneer at the forefront of the alternative pain relief movement.

[Robertscott]

$EMED Our mission


Over 80 million Americans live with moderate to severe pain resulting from an accident or a disease, nearly 40% of them report being unable to find adequate pain relief and 77% report feeling depressed due to their chronic pain.
Our goal is to unlock the body’s natural ability to achieve wellness through high performance electrotherapy technologies, using energy, frequency and vibrations to improve quality of life.
Activists of a drug free approach, we take prescription drug misuse very seriously.
Alarming statistics have highlighted the importance of an alternative method for pain management.

https://electromedtech.com/our-mission/

[Robertscott]

$EMED Electrotherapy can be used to treat a wide range of of acute and chronic pain.
It also supports healing and recovering and can be used for post-surgical discomfort and to boost your body’s natural recovery properties.

[Robertscott]

$EMED Electrotherapy seems to be one of the most promising substitute to toxic and addictive painkillers. Since introducing the WellnessPro+ in 2007, ElectroMedical Technologies has been an innovation pioneer at the forefront of the alternative pain relief movement.

[Robertscott]

$EMED Electrotherapy is a nerve stimulation therapy via carefully developed electrical impulses mimicking our
body signals to help restore damages caused by injuries or accidents.
Significant percentage of patients found TENS devices effectively reduced their pain.

https://electromedtech.com/electrotherapy-explained/

[Robertscott]

$EMED With over a million frequencies to choose from, WellnessPro Plus® offers the widest frequency range on the market allowing it to have numerous applications. FDA CLEARED, it features a “future-ready” modular design, making it widely adaptable to new accessories and therapies.

[Robertscott]

$EMED
The WellnessPro Plus®

triggers our body’s natural processes. Electrical impulses travel from nerves around the injured area to our brain, delivering the unpleasant sensation of pain. WellnessPro Plus® operates by disrupting these pain signals received by our synapses, mimicking our natural electric signals to relieve patients from pain.

Electromedical Technologies brought together some of the leading biomedical researchers from around the world to develop next generation TENS machines. Through product innovation and a forward-thinking approach, we succeeded to develop specific algorithms in electrotherapy that work to alleviate pain.

[Robertscott]

$EMED During the three months ended Dec 31, preliminary revenue increased 79% on a quarterly year-over-year basis and 51% on a sequential quarterly basis.

[Robertscott]

$EMED
The WellnessPro Plus®

triggers our body’s natural processes. Electrical impulses travel from nerves around the injured area to our brain, delivering the unpleasant sensation of pain. WellnessPro Plus® operates by disrupting these pain signals received by our synapses, mimicking our natural electric signals to relieve patients from pain.

Electromedical Technologies brought together some of the leading biomedical researchers from around the world to develop next generation TENS machines. Through product innovation and a forward-thinking approach, we succeeded to develop specific algorithms in electrotherapy that work to alleviate pain.

[Robertscott]

$EMED Electrotherapy seems to be one of the most promising substitute to toxic and addictive painkillers. Since introducing the WellnessPro+ in 2007, ElectroMedical Technologies has been an innovation pioneer at the forefront of the alternative pain relief movement.

[Robertscott]

$EMED Our mission


Over 80 million Americans live with moderate to severe pain resulting from an accident or a disease, nearly 40% of them report being unable to find adequate pain relief and 77% report feeling depressed due to their chronic pain.
Our goal is to unlock the body’s natural ability to achieve wellness through high performance electrotherapy technologies, using energy, frequency and vibrations to improve quality of life.
Activists of a drug free approach, we take prescription drug misuse very seriously.
Alarming statistics have highlighted the importance of an alternative method for pain management.

https://electromedtech.com/our-mission/

[Robertscott]

$EMED Quote https://www.otcmarkets.com/stock/EMED/quote

[Robertscott]

$EMED Electromedical Technologies Announces Preliminary Unaudited Revenue for Q4 and FY 2022 and update on operations

https://finance.yahoo.com/news/electromedical-technologies-announces-preliminary-unaudited-121900011.html

[ProfitScout]

$CURR News: Avenir's Sera Labs Launches Patent Pending DNA Complex with Advanced Peptides and Compounds - Providing Instant and Long-Lasting Results With Daily Use
https://www.accesswire.com/744229/Avenirs-Sera-Labs-Launches-Patent-Pending-DNA-Complex-with-Advanced-Peptides-and-Compounds--Providing-Instant-and-Long-Lasting-Results-With-Daily-Use

[AyaStocks]

$EPAZ could secure significant government contracts worth up to $15 million over the following three years!

[Robertscott]

$NBIO Chart Looking good https://www.stockscores.com/chart.asp?TickerSymbol=NBIO&TimeRange=1300&Interval=d&Volume=1&ChartType=CandleStick&Stockscores=1&ChartWidth=830&ChartHeight=500&LogScale=None&Band=None&avgType1=SMA&movAvg1=&avgType2=SMA&movAvg2=&Indicator1=RSI&Indicator2=AccDist&Indicator3=MACD&Indicator4=None&endDate=&CompareWith=&entryPrice=&stopLossPrice=&candles=redgreen

[Robertscott]

$PVSP is working hard as well to build value to shareholders.

[Robertscott]

$PVSP Overview https://www.otcmarkets.com/stock/PVSP/overview

[Robertscott]

$PVSP SEATTLE, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Pervasip Corp. (OTCPK: PVSP) (“Pervasip” and the “Company”) today announced that it will spin-off 100% of its wholly-owned subsidiary, Artizen Corporation (“Artizen”), as a separate public company, with an anticipated record date between July 1, 2023, and September 30, 2023. As a result of the spin-off, all Pervasip shareholders of record as of the designated record date shall receive shares in the newly public Artizen in proportion to their ownership in Pervasip. Artizen conducts 100% of Pervasip’s cannabis business segment operations through its Zen Asset Management LLC subsidiary ("Zen”).

https://www.nasdaq.com/press-release/pervasip-announces-artizen-spin-off-2023-01-17

[Robertscott]

$PVSP's identification of a series of exciting expansion opportunities, including potential acquisitions involving licensed wholesale and retail operations that would offer Artizen the potential to establish itself as a vertically integrated multi-state operator (“MSO”).

[Robertscott]

$PVSP SEATTLE, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Pervasip Corp. (OTCPK: PVSP) (“Pervasip” and the “Company”) today announced that it will spin-off 100% of its wholly-owned subsidiary, Artizen Corporation (“Artizen”), as a separate public company, with an anticipated record date between July 1, 2023, and September 30, 2023. As a result of the spin-off, all Pervasip shareholders of record as of the designated record date shall receive shares in the newly public Artizen in proportion to their ownership in Pervasip. Artizen conducts 100% of Pervasip’s cannabis business segment operations through its Zen Asset Management LLC subsidiary ("Zen”).

https://www.nasdaq.com/press-release/pervasip-announces-artizen-spin-off-2023-01-17

[Robertscott]

$PVSP Pervasip Corp will still be managed by the current executive management team.

[Robertscott]

$HTSC 65,000,000 shares of Tamino Minerals Inc (OTC: TINO), which is a gold and lithium
exploration company
• 2,200,000,000 shares of IDGlobal Corp. (OTC: IDGC), which owns its own web-based
intellectual property for energy monitoring

[Robertscott]

$HTSC website is:https://heretoserve.tech

[Robertscott]

$PVSP Pervasip previously announced its identification of a series of exciting expansion opportunities, including potential acquisitions involving licensed wholesale and retail operations that would offer Artizen the potential to establish itself as a vertically integrated multi-state operator (“MSO”).

https://www.benzinga.com/markets/cannabis/23/01/30465565/pervasip-announces-artizen-spin-off?utm_campaign=partner_feed&utm_source=MarketWatch&utm_medium=partner_feed&utm_content=site&mod=mw_quote_news

[Robertscott]

$PVSP While the local Washington market presents compelling opportunities for the acquisition and roll-up of wholesale flower, concentrate, and other related production assets by Zen’s independent cultivators, the regulatory environment in Washington prevents vertical integration into retail assets. That limitation is a significant constraint on growth since Zen’s independent cultivators cannot acquire dispensary assets to internalize retail revenues that are typically about three times wholesale receipts. Stated differently, Artizen could be generating about three times its current revenues, or about $46 to $52 million, if Zen’s existing footprint was in another state. Thus, diversification has been and remains a key strategic focus – both within Washington by expanding Zen’s offerings and exploiting compliant acquisition opportunities, and in valuable emerging cannabis markets by replicating Artizen’s proven formula for success in new U.S. and Canadian geographies.

https://www.barrons.com/articles/pervasip-announces-artizen-spin-off-01673965206?mod=md_stockoverview_news

[Robertscott]

$PVSP Weed legalization is already supported by most U.S. voters. And in November, a poll released by Winthrop University(opens in new tab) found that 78% of adults in South Carolina, including a majority of Republicans, would like to see medical cannabis reform. An additional 54% of voters were in favor of recreational weed legalization.

[Robertscott]

$PVSP The current team has cleaned up the business.

[Robertscott]

$PVSP Burtscher added,

“Timing is important. The valuations and fates of MSOs and other participants in the cannabis industry have vacillated in several waves since state legalization commenced. We believe that increased legalization is inevitable in time, both at the federal level and in the form of improved regulatory environments in Washington. Preparing ourselves for that day is an important aspect of our long-term plans, including by expanding our brands and building on our footprint in valuable new geographies, and accessing long term equity capital to do so with shareholder friendly structures. Critically, the Artizen capital structure after the spin-out is completed has been specifically designed to allow us to raise equity financing on terms that vastly exceed anything that we can accomplish with Pervasip’s current capital structure.”

[Robertscott]

$PVSP

“Spinning out Artizen will allow us to properly capitalize the business to take advantage of multiple expansion opportunities to build on our existing foundation,” said German Burtscher, Chairman and Chief Executive Officer of Pervasip and Artizen.

[Bill2]

MEGOLACORP.COM
UPDATE. Audit work, MEDESOL definitive this week, February news
On 5YR $10 million minimum supply agreement.
Guys $MGON close to 0.01
Last run to .25

[Robertscott]

$PVSP Pervasip common shareholders will receive 15% or 15,000,000 shares in Artizen Corp at the Record Date
The Record Date is the day end of day before the date at which the new Artizen Ticker goes life
Pervasip are not shortchanged. On an as if fully diluted basis, all Pervasip common shares amount to approximately 13.8% of all outstanding shares; we set 15% aside for all common shareholders in Artizen Corp

[Robertscott]

$PVSP
Pervasip Corp (PK)
0.0006
+ 0.0001 (20.00%)
Volume: 3,821,399
Day Range: 0.0005 - 0.0006
Last Trade Time: 2:09:06 PM EST

[Robertscott]

$PVSP From the latest release:

Burtscher added, “Timing is important. The valuations and fates of MSOs and other participants in the cannabis industry have vacillated in several waves since state legalization commenced. We believe that increased legalization is inevitable in time, both at the federal level and in the form of improved regulatory environments in Washington. Preparing ourselves for that day is an important aspect of our long-term plans, including by expanding our brands and building on our footprint in valuable new geographies, and accessing long term equity capital to do so with shareholder friendly structures. Critically, the Artizen capital structure after the spin-out is completed has been specifically designed to allow us to raise equity financing on terms that vastly exceed anything that we can accomplish with Pervasip’s current capital structure.”

https://www.bloomberg.com/press-releases/2023...n-spin-off

[Bruce the Stock Guy]

$KEGS..Churning 00055's before the next leg up..Expanding rapidly in the tasty beer biz!

[Robertscott]

PVSP

“Spinning out Artizen will allow us to properly capitalize the business to take advantage of multiple expansion opportunities to build on our existing foundation,” said German Burtscher, Chairman and Chief Executive Officer of Pervasip and Artizen.